Fair Value Measurements and Investments - Schedule of Reconciliation For Contingent Consideration Measured At Fair Value Using Significant Unobservable Inputs (Level 3) (Detail) - Neo Medical [Member] - Fair Value, Inputs, Level 3 [Member] - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of convertible loans beginning balance	$ 7,148	$ 7,160
Interest recognized in interest income, net	326	305
Foreign currency remeasurement recognized in other expense, net	(437)	(270)
Unrealized loss recognized in other comprehensive loss	(766)	(115)
Conversion of loan into preferred equity securities	(671)
Fair value of convertible loans ending balance	5,600	7,080
Amortized cost basis of Neo Medical Convertible Loans at September 30	$ 5,425	$ 5,314